{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T16:40:09Z","timestamp":1793032809293,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019305","name":"Manipal Academy of Higher Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019305","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019304","name":"Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019304","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics: X"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ijpx.2026.100593","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T15:40:13Z","timestamp":1782920413000},"page":"100593","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Quality by design-based development of ibrutinib polymer-lipid hybrid nanoparticles for enhanced lymphatic absorption and anticancer efficacy"],"prefix":"10.1016","volume":"12","author":[{"given":"Pragathi Devanand","family":"Bangera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshatha P.","family":"Kamath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adarsh","family":"Gopinathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahesha","family":"Keerikkadu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshay","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vamshi Krishna","family":"Tippavajhala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahalaxmi","family":"Rathnanand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpx.2026.100593_bb0005","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejpb.2023.10.016","article-title":"Pharmacokinetics of cycloheximide in rats and evaluation of its effect as a blocker of intestinal lymph formation","volume":"193","author":"Al Nebaihi","year":"2023","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpx.2026.100593_bb0010","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1007\/s10876-022-02283-w","article-title":"Caffeic acid loaded lipid polymer hybrid nanoparticles: Ex vivo and pre-clinical evaluation against liver cirrhosis","volume":"34","author":"Ansari","year":"2023","journal-title":"J. Clust. Sci."},{"key":"10.1016\/j.ijpx.2026.100593_bb0015","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3390\/molecules27010168","article-title":"Development of sustained release baricitinib loaded lipid-polymer hybrid nanoparticles with improved oral bioavailability","volume":"27","author":"Anwer","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ijpx.2026.100593_bb0020","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-023-02576-x","article-title":"Highlights on cell-penetrating peptides and polymer-lipid hybrid nanoparticle: Overview and therapeutic applications for targeted anticancer therapy","volume":"24","author":"Bangera","year":"2023","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpx.2026.100593_bb0025","doi-asserted-by":"crossref","first-page":"361","DOI":"10.22159\/ijap.2025v17i5.54683","article-title":"Analytical QBD integrated RP-HPLC method development and optimization for high-precision quantification of ibrutinib in hybrid nanocarrier systems","author":"Bangera","year":"2025","journal-title":"Int. J. Appl. Pharm."},{"key":"10.1016\/j.ijpx.2026.100593_bb0035","series-title":"Pathology and Epidemiology of Cancer","first-page":"543","article-title":"Epidemiology of hematologic malignancies","author":"Batista","year":"2017"},{"key":"10.1016\/j.ijpx.2026.100593_bb0050","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.mimet.2019.03.017","article-title":"Lipid-polymer hybrid nanoparticles: Synthesis strategies and biomedical applications","volume":"160","author":"Dave","year":"2019","journal-title":"J. Microbiol. Methods"},{"key":"10.1016\/j.ijpx.2026.100593_bb0055","doi-asserted-by":"crossref","first-page":"506","DOI":"10.35516\/jjps.v17i3.2384","article-title":"Nanomedicine advancements in cancer therapy: a scientific review","volume":"17","author":"Dayyih","year":"2024","journal-title":"Jordan J. Pharmaceut. Sci."},{"key":"10.1016\/j.ijpx.2026.100593_bb0060","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/02652048.2022.2051625","article-title":"Optimisation and evaluation of Gymnema sylvestre extract loaded polymeric nanoparticles for enhancement of in vivo efficacy and reduction of toxicity","volume":"39","author":"Dewangan","year":"2022","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ijpx.2026.100593_bb0065","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejpb.2023.07.008","article-title":"Quality by design endorsed fabrication of Ibrutinib-loaded human serum albumin nanoparticles for the management of leukemia","volume":"190","author":"Famta","year":"2023","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpx.2026.100593_bb0070","doi-asserted-by":"crossref","first-page":"16958","DOI":"10.1021\/la103576a","article-title":"Quick synthesis of lipid\u2212polymer hybrid nanoparticles with low polydispersity using a single-step sonication method","volume":"26","author":"Fang","year":"2010","journal-title":"Langmuir"},{"key":"10.1016\/j.ijpx.2026.100593_bb0075","series-title":"Characterization of Nanoencapsulated Food Ingredients","first-page":"213","article-title":"Surface charge (zeta-potential) of nanoencapsulated food ingredients","author":"Feng","year":"2020"},{"key":"10.1016\/j.ijpx.2026.100593_bb0080","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s40262-020-00931-w","article-title":"The interplay between Liver First-Pass effect and lymphatic absorption of cannabidiol and its implications for cannabidiol oral formulations","volume":"59","author":"Franco","year":"2020","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ijpx.2026.100593_bb0085","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12943-023-01849-0","article-title":"Lipid polymer hybrid nanoparticles: a custom-tailored next-generation approach for cancer therapeutics","volume":"22","author":"Gajbhiye","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ijpx.2026.100593_bb0095","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1208\/s12248-012-9389-7","article-title":"Characterization of supersaturatable formulations for improved absorption of poorly soluble drugs","volume":"14","author":"Gao","year":"2012","journal-title":"AAPS J."},{"key":"10.1016\/j.ijpx.2026.100593_bb0100","doi-asserted-by":"crossref","first-page":"638","DOI":"10.3390\/nano9040638","article-title":"Lipid-based nanoparticles: application and recent advances in cancer treatment","volume":"9","author":"Garc\u00eda-Pinel","year":"2019","journal-title":"Nanomaterials"},{"key":"10.1016\/j.ijpx.2026.100593_bb0105","series-title":"2009 2nd International Conference on Biomedical Engineering and Informatics","first-page":"1","article-title":"Enhanced cytotoxicity suppression of arsenic trioxide to leukemia cancer cells by using magnetic nanoparticles","author":"Guo","year":"2009"},{"key":"10.1016\/j.ijpx.2026.100593_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/gels10030169","article-title":"Lecithin\u2019s roles in oleogelation","volume":"10","author":"Harasym","year":"2024","journal-title":"Gels"},{"key":"10.1016\/j.ijpx.2026.100593_bb0115","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40543-021-00276-4","article-title":"A simple, precise, and sensitive HPLC method for quantification of letrozole in rat plasma: development, validation, and preclinical pharmacokinetics","volume":"12","author":"Hegde","year":"2021","journal-title":"J Anal Sci Technol"},{"key":"10.1016\/j.ijpx.2026.100593_bb0125","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1208\/s12249-023-02621-9","article-title":"In silico screening as a tool to prepare drug-drug cocrystals of ibrutinib-ketoconazole: a strategy to enhance their solubility profiles and oral bioavailability","volume":"24","author":"Kara","year":"2023","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpx.2026.100593_bb0130","article-title":"Integrative green synthesis and molecular simulation of ibrutinib cocrystals for enhanced biopharmaceutical performance and in vivo pharmacokinetics","volume":"10","author":"Kara","year":"2025","journal-title":"Int. J. Pharmaceut. X"},{"key":"10.1016\/j.ijpx.2026.100593_bb0135","doi-asserted-by":"crossref","first-page":"16096","DOI":"10.1038\/nrdp.2016.96","article-title":"Chronic lymphocytic leukaemia","volume":"3","author":"Kipps","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ijpx.2026.100593_bb0140","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ijpharm.2017.10.011","article-title":"Enhanced solubility and bioavailability of simvastatin by mechanochemically obtained complexes","volume":"534","author":"Kong","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2026.100593_bb0145","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.bbamem.2017.02.008","article-title":"Accumulation of phosphatidylcholine on gut mucosal surface is not dominated by electrostatic interactions","volume":"1859","author":"Korytowski","year":"2017","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.ijpx.2026.100593_bb0150","doi-asserted-by":"crossref","first-page":"1517972","DOI":"10.3389\/fphar.2024.1517972","article-title":"Managing novel therapies and concomitant medications in chronic lymphocytic leukemia: key challenges","volume":"15","author":"Kozarac","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijpx.2026.100593_bb0155","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1039\/C4BM00427B","article-title":"Lipid-coated polymeric nanoparticles for cancer drug delivery","volume":"3","author":"Krishnamurthy","year":"2015","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.ijpx.2026.100593_bb0160","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1039\/D5SM00006H","article-title":"Recent advances in nanoprecipitation: from mechanistic insights to applications in nanomaterial synthesis","volume":"21","author":"Kuddushi","year":"2025","journal-title":"Soft Matter"},{"key":"10.1016\/j.ijpx.2026.100593_bb0165","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.canep.2014.12.001","article-title":"Racial differences in three major NHL subtypes: Descriptive epidemiology","volume":"39","author":"Li","year":"2015","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.ijpx.2026.100593_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17020221","article-title":"Oral administration of neratinib maleate-loaded lipid\u2013polymer hybrid nanoparticles: optimization, physical characterization, and in vivo evaluation","volume":"17","author":"Mahajan","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpx.2026.100593_bb0175","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s13596-024-00770-1","article-title":"A comprehensive review on pleiotropic effects and therapeutic potential of soy lecithin","volume":"25","author":"Mangrulkar","year":"2025","journal-title":"ADV TRADIT MED (ADTM)"},{"key":"10.1016\/j.ijpx.2026.100593_bb0180","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.biomaterials.2018.10.012","article-title":"Chylomicron-pretended nano-bio self-assembling vehicle to promote lymphatic transport and GALTs target of oral drugs","volume":"188","author":"Mao","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpx.2026.100593_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/3021738","article-title":"Intestinal permeability of artesunate-loaded solid lipid nanoparticles using the everted gut method","volume":"2018","author":"Masiiwa","year":"2018","journal-title":"J. Drug Deliv."},{"key":"10.1016\/j.ijpx.2026.100593_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.123784","article-title":"Dasatinib loaded mucoadhesive lecithin-chitosan hybrid nanoparticles for its augmented oral delivery, in-vitro efficacy and safety","volume":"651","author":"Mehandole","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2026.100593_bb0195","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jddst.2019.01.014","article-title":"Disodium salt of glycyrrhizic acid \u2013 a novel supramolecular delivery system for anthelmintic drug praziquantel","volume":"50","author":"Meteleva","year":"2019","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.ijpx.2026.100593_bb0200","first-page":"213","article-title":"Development and optimization of lipid-polymer hybrid nanoparticles containing melphalan using central composite design and its effect on ovarian cancer cell lines","volume":"20","author":"Mirnezami","year":"2021","journal-title":"Iran. J. Pharmaceut. Res. IJPR"},{"key":"10.1016\/j.ijpx.2026.100593_bb0205","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1577331","article-title":"Escitalopram oxalate-loaded chitosan nanoparticle in situ gel formulation intended for direct nose-to-brain delivery: in vitro, ex vivo, and in vivo pharmacokinetic evaluation","volume":"16","author":"Mujtaba","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijpx.2026.100593_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119731","article-title":"Self-assembled lecithin-chitosan nanoparticles improve the oral bioavailability and alter the pharmacokinetics of raloxifene","volume":"588","author":"Murthy","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2026.100593_bb0215","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.21037\/atm-20-5546","article-title":"CAR T-cell therapy in mature lymphoid malignancies: clinical opportunities and challenges","volume":"9","author":"Narkhede","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.ijpx.2026.100593_bb0220","doi-asserted-by":"crossref","first-page":"9567","DOI":"10.1021\/acsnano.7b07214","article-title":"New Insights into \u201cPermeability\u201d as in the Enhanced Permeability and Retention effect of Cancer Nanotherapeutics","volume":"11","author":"Nel","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijpx.2026.100593_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.ab.2020.113937","article-title":"Optimization and application of MTT assay in determining density of suspension cells","volume":"610","author":"Nga","year":"2020","journal-title":"Anal. Biochem."},{"issue":"2","key":"10.1016\/j.ijpx.2026.100593_bb0230","first-page":"1977","article-title":"Chitosan nanocarrier system for tumour targeting","volume":"5","author":"Pandian","year":"2019","journal-title":"Int. J. Adv. Res. Ideas Innov. Technol."},{"key":"10.1016\/j.ijpx.2026.100593_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2021.102585","article-title":"Nanocarriers based oral lymphatic drug targeting: Strategic bioavailability enhancement approaches","volume":"64","author":"Pandya","year":"2021","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.ijpx.2026.100593_bb0240","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1208\/s12249-023-02586-9","article-title":"Core shell lipid-polymer hybrid nanoparticles for oral bioavailability enhancement of ibrutinib via lymphatic uptake","volume":"24","author":"Patel","year":"2023","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpx.2026.100593_bb0245","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.actbio.2019.05.030","article-title":"Targeted delivery of ibrutinib to tumor-associated macrophages by sialic acid-stearic acid conjugate modified nanocomplexes for cancer immunotherapy","volume":"92","author":"Qiu","year":"2019","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ijpx.2026.100593_bb0250","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.3762\/bjnano.15.118","article-title":"Polymer lipid hybrid nanoparticles for phytochemical delivery: challenges, progress, and future prospects","volume":"15","author":"Rahat","year":"2024","journal-title":"Beilstein J. Nanotechnol."},{"key":"10.1016\/j.ijpx.2026.100593_bb0255","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jconrel.2023.05.001","article-title":"Design of experiments in the optimization of nanoparticle-based drug delivery systems","volume":"358","author":"Rampado","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100593_bb0260","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1208\/s12249-019-1524-7","article-title":"Fabrication of ibrutinib nanosuspension by quality by design approach: intended for enhanced oral bioavailability and diminished fast fed variability","volume":"20","author":"Rangaraj","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpx.2026.100593_bb0265","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.3389\/fphar.2018.01260","article-title":"PLGA-based nanoparticles in cancer treatment","volume":"9","author":"Rezvantalab","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijpx.2026.100593_bb0270","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6528\/ac1098","article-title":"Exemestane encapsulated polymer-lipid hybrid nanoparticles for improved efficacy against breast cancer: Optimization, in vitro characterization and cell culture studies","volume":"32","author":"Rizwanullah","year":"2021","journal-title":"Nanotechnology"},{"key":"10.1016\/j.ijpx.2026.100593_bb0275","doi-asserted-by":"crossref","first-page":"i3","DOI":"10.1093\/annonc\/mdl443","article-title":"Epidemiology of hematological malignancies","volume":"18","author":"Rodriguez-Abreu","year":"2007","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ijpx.2026.100593_bb0280","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1124\/dmd.114.060061","article-title":"Absorption, metabolism, and excretion of oral 14C radiolabeled ibrutinib: an open-label, phase I, single-dose study in healthy men","volume":"43","author":"Scheers","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ijpx.2026.100593_bb0285","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/00914037.2020.1809406","article-title":"Lipid-polymer hybrid nanoparticles as a targeted drug delivery system for melanoma treatment","volume":"71","author":"Scopel","year":"2022","journal-title":"Int. J. Polym. Mater. Polym. Biomater."},{"key":"10.1016\/j.ijpx.2026.100593_bb0290","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1025013","article-title":"Formulation development of lipid polymer hybrid nanoparticles of doxorubicin and its in-vitro, in-vivo and computational evaluation","volume":"14","author":"Shafique","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijpx.2026.100593_bb0295","article-title":"An overview of advanced nanocarrier systems for Ibrutinib delivery: overcoming pharmacokinetic barriers and enabling targeted cancer therapy","volume":"10","author":"Shetty","year":"2025","journal-title":"Int. J. Pharmaceut. X"},{"key":"10.1016\/j.ijpx.2026.100593_bb0300","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.3390\/pharmaceutics16101305","article-title":"Stable polymer-lipid hybrid nanoparticles based on mcl-polyhydroxyalkanoate and cationic liposomes for mRNA delivery","volume":"16","author":"Shishlyannikov","year":"2024","journal-title":"Pharmaceutics"},{"issue":"21","key":"10.1016\/j.ijpx.2026.100593_bb0305","doi-asserted-by":"crossref","first-page":"6874","DOI":"10.1039\/D5NA00386E","article-title":"Improving oral bioavailability of acalabrutinib using polymer\u2013lipid hybrid nanoparticles: design, optimization, and in vivo pharmacokinetic evaluation","volume":"7","author":"Sinha","year":"2025","journal-title":"Nanosc. Adv."},{"key":"10.1016\/j.ijpx.2026.100593_bb0310","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13081291","article-title":"Polymeric lipid hybrid nanoparticles (PLNs) as emerging drug delivery platform\u2014a comprehensive review of their properties, preparation methods, and therapeutic applications","volume":"13","author":"Sivadasan","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpx.2026.100593_bb0315","article-title":"Polymer-hybrid nanoparticles: current advances in biomedical applications","volume":"131","author":"Soares","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijpx.2026.100593_bb0325","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/nano6020026","article-title":"Manufacturing techniques and surface engineering of polymer based nanoparticles for targeted drug delivery to cancer","volume":"6","author":"Wang","year":"2016","journal-title":"Nanomaterials"},{"key":"10.1016\/j.ijpx.2026.100593_bb0330","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1124\/pr.110.002584","article-title":"A critical analysis of the interplay between cytochrome P450 3A and P-glycoprotein: recent insights from knockout and transgenic mice","volume":"63","author":"van Waterschoot","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ijpx.2026.100593_bb0335","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1177\/10781552221090869","article-title":"Real-world management of targeted therapies in chronic lymphocytic leukemia","volume":"28","author":"Weis","year":"2022","journal-title":"J. Oncol. Pharm. Pract."},{"key":"10.1016\/j.ijpx.2026.100593_bb0345","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3390\/jpm11080771","article-title":"The Enhanced Permeability and Retention (EPR) effect: the significance of the concept and methods to enhance its application","volume":"11","author":"Wu","year":"2021","journal-title":"J. Personaliz. Med."},{"key":"10.1016\/j.ijpx.2026.100593_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodhyd.2024.110168","article-title":"Interactions with soy lecithin regulate the emulsification capacity of pea protein: Effects of soy lecithin concentration","volume":"155","author":"Xia","year":"2024","journal-title":"Food Hydrocoll."},{"key":"10.1016\/j.ijpx.2026.100593_bb0355","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ejpb.2023.02.016","article-title":"Regorafenib loaded self-assembled lipid-based nanocarrier for colorectal cancer treatment via lymphatic absorption","volume":"185","author":"Xia","year":"2023","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpx.2026.100593_bb0365","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ijpharm.2018.06.063","article-title":"Development and characterization of gemcitabine hydrochloride loaded lipid polymer hybrid nanoparticles (LPHNs) using central composite design","volume":"548","author":"Yalcin","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2026.100593_bb0370","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.3390\/polym16182606","article-title":"Recent applications of PLGA in drug delivery systems","volume":"16","author":"Yang","year":"2024","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.ijpx.2026.100593_bb0375","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.4435","article-title":"Simple determination of plasma ibrutinib concentration using high-performance liquid chromatography","volume":"33","author":"Yasu","year":"2019","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.ijpx.2026.100593_bb0380","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.3390\/mi13122091","article-title":"Hemolytic activity of Nanoparticles as a marker of their hemocompatibility","volume":"13","author":"Yedgar","year":"2022","journal-title":"Micromachines"},{"key":"10.1016\/j.ijpx.2026.100593_bb0385","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1142\/S179398441000016X","article-title":"Lipid\u2013polymer hybrid nanoparticles: Synthesis, characterization and applications","volume":"01","author":"Zhang","year":"2010","journal-title":"Nano Life"},{"key":"10.1016\/j.ijpx.2026.100593_bb0390","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41408-023-00853-3","article-title":"Global burden of hematologic malignancies and evolution patterns over the past 30 years","volume":"13","author":"Zhang","year":"2023","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.ijpx.2026.100593_bb0395","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.2147\/IJN.S462374","article-title":"2-Monoacylglycerol mimetic liposomes to promote intestinal lymphatic transport for improving oral bioavailability of dihydroartemisinin","volume":"19","author":"Zheng","year":"2024","journal-title":"IJN"}],"container-title":["International Journal of Pharmaceutics: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590156726001131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590156726001131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T16:07:02Z","timestamp":1793030822000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590156726001131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":71,"alternative-id":["S2590156726001131"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpx.2026.100593","relation":{},"ISSN":["2590-1567"],"issn-type":[{"value":"2590-1567","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality by design-based development of ibrutinib polymer-lipid hybrid nanoparticles for enhanced lymphatic absorption and anticancer efficacy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpx.2026.100593","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100593"}}